Persistent cough: Causes and remedies

Introduction

Persistent cough, defined as a cough lasting longer than eight weeks in adults or four weeks in children, represents a common clinical presentation with multifactorial etiologies. The symptom often signals underlying respiratory or systemic pathology and can substantially reduce quality of life. Historically, cough has been studied as a protective reflex, with early descriptions dating back to the works of Galen and later refined by modern neurophysiological investigations. Within pharmacology, the management of persistent cough necessitates a nuanced understanding of both the underlying mechanisms and the therapeutic agents that modulate them. For medical and pharmacy students, mastery of this topic is essential for accurate diagnosis, rational drug selection, and effective patient counseling.

• Define persistent cough and its clinical relevance.
• Identify major physiological and pathological contributors.
• Understand pharmacologic principles guiding antitussive therapy.
• Apply case-based reasoning to therapeutic decision making.
• Recognize potential adverse effects and drug interactions.

Fundamental Principles

Cough Reflex Anatomy and Physiology

The cough reflex is mediated by afferent fibers of the vagus nerve, particularly the internal laryngeal and tracheobronchial receptors. These sensors detect mechanical irritation, chemical stimuli, and inflammatory mediators. The afferent signal travels to the cough center within the medulla oblongata, which coordinates motor output via the spinal cord and various cranial nerves to produce the characteristic cough waveform. The cough center integrates inputs from higher cortical areas, allowing modulation of the reflex in response to conscious control.

Classification of Cough

Cough is conventionally divided into acute (24 weeks) categories. Persistent cough occupies an intermediate zone, commonly defined as lasting between 4 and 8 weeks in children and 4 to 12 weeks in adults. The classification aids in guiding differential diagnosis and therapeutic strategies.

Key Terminology

• Bronchial hyperresponsiveness: exaggerated bronchoconstriction in response to stimuli.
• Postnasal drip: mucus drainage from the nasopharynx into the oropharynx.
• Gastro‑oesophageal reflux disease (GERD): backflow of gastric contents provoking cough.
• Upper airway cough syndrome (UACS): cough secondary to chronic rhinosinusitis or allergic rhinitis.
• Non‑asthmatic cough hypersensitivity syndrome: heightened sensory perception of airway stimuli without overt asthma.

Detailed Explanation

Pathophysiological Mechanisms

Persistent cough arises from a combination of peripheral and central factors. Peripheral mechanisms involve airway irritation or inflammation that stimulates cough receptors. Central mechanisms encompass altered processing of afferent signals within the cough center, leading to exaggerated responsiveness. The interplay between these mechanisms is illustrated by the relationship: Cough frequency = Peripheral stimulus intensity × Central sensitivity. In mathematical terms, this can be conceptualized as:

C(t) = C₀ × e⁻ᵏᵗ,

where C(t) represents cough frequency at time t, C₀ is the baseline frequency, and k is the decay constant reflecting resolution of the stimulus. In chronic conditions, k may be reduced, sustaining elevated cough rates.

Inflammatory Mediators and Neurogenic Inflammation

Substance P, calcitonin gene‑related peptide (CGRP), and nerve growth factor (NGF) are prominent neuropeptides released during airway inflammation. These mediators sensitize cough receptors and increase neural excitability. Cytokines such as interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) further propagate inflammatory cascades, reinforcing the cough reflex loop.

Role of the Airway Microbiome

Emerging evidence indicates that alterations in the respiratory microbiome may influence cough sensitivity. Dysbiosis can promote a pro‑inflammatory milieu, leading to heightened receptor activation. While the causal relationship remains under investigation, therapeutic modulation of the microbiome could represent a future avenue for cough management.

Environmental and Lifestyle Factors

• Smoking: chronic exposure induces mucosal damage and upregulates cough receptors.
• Air pollution: particulate matter triggers oxidative stress, enhancing inflammation.
• Occupational exposures: inhalation of irritants such as silica or asbestos increases cough risk.
• Alcohol and caffeine: both can provoke transient cough in susceptible individuals.

Pharmacokinetic Considerations in Antitussive Therapy

Drug efficacy depends on absorption, distribution, metabolism, and excretion (ADME). The concentration–time profile follows: C(t) = (Dose × F) ÷ (V_d × k_el) × e⁻ᵏᵉᶫt, where F is bioavailability, V_d is volume of distribution, k_el is elimination rate constant, and t is time. Understanding these parameters informs dosing intervals and potential accumulation in populations with altered clearance, such as the elderly or those with hepatic impairment.

Clinical Significance

Relevance to Drug Therapy

Persistent cough is frequently encountered in primary care, requiring judicious selection of antitussive agents. Pharmacologic options encompass centrally acting agents (e.g., codeine, dextromethorphan), peripheral agents (e.g., antihistamines, proton pump inhibitors), and combination preparations. Each class targets distinct pathophysiological pathways, with efficacy influenced by the underlying cause.

Practical Applications

1. Assessment of etiology: Structured history and physical examination, supplemented by investigations such as chest radiography, spirometry, and pH monitoring, delineate cause-specific therapy.
2. Drug selection: For cough secondary to postnasal drip, antihistamines or intranasal corticosteroids may be prioritized. In GERD‑associated cough, acid suppression therapy is first line.
3. Monitoring and adjustment: Serial reassessment of cough intensity, using validated scales (e.g., cough visual analogue scale), guides therapeutic titration.

Clinical Examples

A 52‑year‑old woman presents with a 6‑week cough. Imaging reveals chronic rhinosinusitis; intranasal steroids reduce mucosal inflammation, leading to cough resolution. Conversely, a 35‑year‑old man with a productive cough for 10 weeks has pulmonary tuberculosis; antitussive therapy is secondary to anti‑tuberculous regimen.

Clinical Applications/Examples

Case Scenario 1: Postnasal Drip‑Associated Cough

A 28‑year‑old female reports a dry, non‑productive cough lasting 5 weeks, exacerbated by lying down. Examination reveals nasal congestion and rhinorrhea. Management involves a nasal antihistamine (e.g., cetirizine 10 mg daily) combined with intranasal corticosteroid spray. Symptomatic relief is expected within 1–2 weeks. If cough persists, a short course of antihistamine‑anticholinergic combination may be considered.

Case Scenario 2: GERD‑Mediated Cough

A 63‑year‑old male experiences a chronic cough that worsens after meals. Upper endoscopy shows esophagitis. Initiation of a proton pump inhibitor (omeprazole 20 mg twice daily) and lifestyle modifications (elevated head of bed, weight loss) should ameliorate acid exposure, thereby reducing cough frequency. Persistent cough after 8 weeks warrants re‑evaluation for esophageal motility disorders or alternative causes.

Case Scenario 3: Asthma‑Related Persistent Cough

A 45‑year‑old smoker presents with a 4‑week cough, wheeze, and exercise intolerance. Spirometry demonstrates reversible airflow limitation. Inhaled corticosteroid–long‑acting beta‑agonist therapy is initiated. Cough often improves within 4–6 weeks of adequate anti‑inflammatory treatment. If cough remains, consideration of cough‑hypersensitivity syndrome or concurrent airway infection is warranted.

Case Scenario 4: Post‑Infectious Cough

A 30‑year‑old female recovers from a viral upper respiratory infection but continues to cough for 6 weeks. Antitussive therapy with dextromethorphan (30 mg every 6–8 hours) is administered, alongside reassurance that cough is likely resolving spontaneously. If cough persists beyond 8 weeks, further evaluation for chronic bronchitis or other etiologies is indicated.

Summary/Key Points

• Persistent cough reflects a complex interplay between peripheral irritation and central sensitization.
• Major etiologies include postnasal drip, GERD, asthma, chronic bronchitis, and post‑infectious changes.
• Pharmacologic management targets the underlying cause and may involve antihistamines, proton pump inhibitors, inhaled corticosteroids, or centrally acting antitussives.
• Drug efficacy depends on pharmacokinetic parameters; dosing adjustments are essential in impaired hepatic or renal function.
• Case‑based reasoning enhances diagnostic accuracy and therapeutic precision.

Clinical pearls:

• The cough frequency equation C(t) = C₀ × e⁻ᵏᵗ offers a conceptual framework for understanding resolution dynamics.
• Monitoring cough intensity with validated scales improves objective assessment of therapeutic response.
• Adverse effect profiles of antitussives, such as CNS depression with codeine, necessitate cautious prescribing, especially in patients with concomitant opioid use.

By integrating knowledge of cough pathophysiology with evidence‑based pharmacologic approaches, medical and pharmacy students can refine their diagnostic acumen and optimize patient outcomes in the management of persistent cough.

References

1. Porter RS. The Merck Manual of Diagnosis and Therapy. 20th ed. Kenilworth, NJ: Merck Sharp & Dohme Corp; 2018.
2. Waller DG, Sampson AP. Medical Pharmacology and Therapeutics. 6th ed. Edinburgh: Elsevier; 2022.
3. Bennett PN, Brown MJ, Sharma P. Clinical Pharmacology. 12th ed. Edinburgh: Elsevier; 2019.
4. Feather A, Randall D, Waterhouse M. Kumar and Clark's Clinical Medicine. 10th ed. London: Elsevier; 2020.
5. Ralston SH, Penman ID, Strachan MWJ, Hobson RP. Davidson's Principles and Practice of Medicine. 24th ed. Edinburgh: Elsevier; 2022.
6. Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill Education; 2022.
7. Rang HP, Ritter JM, Flower RJ, Henderson G. Rang & Dale's Pharmacology. 9th ed. Edinburgh: Elsevier; 2020.
8. Trevor AJ, Katzung BG, Kruidering-Hall M. Katzung & Trevor's Pharmacology: Examination & Board Review. 13th ed. New York: McGraw-Hill Education; 2022.